These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7040867)

  • 21. Hereditary hemorrhagic telangiectasia/avastin.
    Davidson TM; Olitsky SE; Wei JL
    Laryngoscope; 2010 Feb; 120(2):432-5. PubMed ID: 19998344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of treatment for epistaxis secondary to hereditary hemorrhagic telangiectasia.
    Hitchings AE; Lennox PA; Lund VJ; Howard DJ
    Am J Rhinol; 2005; 19(1):75-8. PubMed ID: 15794079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The treatment of recurrent epistaxis due to hereditary haemorrhagic telangiectasia with intranasal bevacizumab.
    Alderman C; Corlett J; Cullis J
    Br J Haematol; 2013 Aug; 162(4):547-8. PubMed ID: 23672440
    [No Abstract]   [Full Text] [Related]  

  • 24. [Surgical treatment of the endonasal manifestations of Rendu-Osler disease].
    Gignoux M; Martin H; Cajgfinger H; Gignoux B; Gadot P
    J Med Lyon; 1970 Nov; 51(197):1967-8 passim. PubMed ID: 4949976
    [No Abstract]   [Full Text] [Related]  

  • 25. Intranasal topical estrogen in the management of epistaxis in hereditary hemorrhagic telangiectasia.
    Minami K; Haji T
    Acta Otolaryngol; 2016; 136(5):528-31. PubMed ID: 26808464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Research progress of bevacizumab in the treatment of refractory epistaxis caused by hereditary hemorrhagic telangiectasia].
    Xu C; Wang HT
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jun; 51(6):476-9. PubMed ID: 27345893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New classification of nasal vasculature patterns in hereditary hemorrhagic telangiectasia.
    Mahoney EJ; Shapshay SM
    Am J Rhinol; 2006; 20(1):87-90. PubMed ID: 16539301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intranasal tranexamic acid for the treatment of hereditary hemorrhagic telangiectasia: a case report and review of treatment options.
    Flanagan BA; Collins C; Parra S
    Cutis; 2012 Feb; 89(2):69-72. PubMed ID: 22474728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Technique modifications for septodermoplasty: an illustrative case.
    Bastianelli M; Kilty SJ
    J Otolaryngol Head Neck Surg; 2015 Dec; 44():59. PubMed ID: 26714786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thalidomide for the Management of Bleeding Episodes in Patients with Hereditary Hemorrhagic Telangiectasia: Effects on Epistaxis Severity Score and Quality of Life.
    Baysal M; Ümit EG; Kırkızlar HO; Özdöver AC; Demir AM
    Turk J Haematol; 2019 Feb; 36(1):43-47. PubMed ID: 29880465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topical timolol for the treatment of epistaxis in hereditary hemorrhagic telangiectasia.
    Olitsky SE
    Am J Otolaryngol; 2012; 33(3):375-6. PubMed ID: 22079094
    [No Abstract]   [Full Text] [Related]  

  • 32. Narrow-band imaging in the endoscopic evaluation of hereditary hemorrhagic telangiectasia patients.
    Pagella F; Pusateri A; Chu F; Caputo M; Danesino C; Matti E
    Laryngoscope; 2013 Dec; 123(12):2967-8. PubMed ID: 23929661
    [No Abstract]   [Full Text] [Related]  

  • 33. Control of nose bleeds in hereditary haemorrhagic telangiectasia.
    Dunshea MG
    N Z Med J; 1970 Jan; 71(452):23-6. PubMed ID: 5265867
    [No Abstract]   [Full Text] [Related]  

  • 34. Taking thalidomide out of rehab.
    Akhurst RJ
    Nat Med; 2010 Apr; 16(4):370-2. PubMed ID: 20376039
    [No Abstract]   [Full Text] [Related]  

  • 35. Nintedanib as a novel treatment option in hereditary haemorrhagic telangiectasia.
    Kovacs-Sipos E; Holzmann D; Scherer T; Soyka MB
    BMJ Case Rep; 2017 Jun; 2017():. PubMed ID: 28652319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Control of epistaxis in patients with hereditary hemorrhagic telangiectasia.
    Siegel MB; Keane WM; Atkins JF; Rosen MR
    Otolaryngol Head Neck Surg; 1991 Nov; 105(5):675-9. PubMed ID: 1754250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fiberoptic bronchoscope and Nd-YAG laser in treatment of severe epistaxis from nasal hereditary hemorrhagic telangectasia and hemangioma.
    Mehta AC; Livingston DR; Levine HL
    Chest; 1987 May; 91(5):791-2. PubMed ID: 3568789
    [No Abstract]   [Full Text] [Related]  

  • 38. Thalidomide for Epistaxis in Patients with Hereditary Hemorrhagic Telangiectasia: A Preliminary Study.
    Fang J; Chen X; Zhu B; Ye H; Zhang W; Guan J; Su K
    Otolaryngol Head Neck Surg; 2017 Aug; 157(2):217-221. PubMed ID: 28418273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of unusually high doses of tranexamic acid for the treatment of epistaxis in hereditary hemorrhagic telangiectasia.
    Sabbà C; Gallitelli M; Palasciano G
    N Engl J Med; 2001 Sep; 345(12):926. PubMed ID: 11565536
    [No Abstract]   [Full Text] [Related]  

  • 40. Antiestrogen therapy for hereditary hemorrhagic telangiectasia: a double-blind placebo-controlled clinical trial.
    Yaniv E; Preis M; Hadar T; Shvero J; Haddad M
    Laryngoscope; 2009 Feb; 119(2):284-8. PubMed ID: 19160429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.